Skip to main content

CRL research · 13F holders by reporting quarter

Charles River Laboratories International, Inc. (CRL): 13F holders, 2025Q4

The largest share positions in CRL that the managers Kresmion follows reported on Form 13F for 2025Q4, as filed. The current quarter, the company's SEC filings and its recent events are on the CRL research page.

CRL positions held by the managers we follow (2025Q4)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported valueQoQ
D. E. Shaw & Co., Inc. FundCUSIP 159864107 · 2025Q4$86M0.07%+1562.3%
CITADEL ADVISORS LLC FundCUSIP 159864107 · 2025Q4$83.3M0.06%n/a
MILLENNIUM MANAGEMENT LLC FundCUSIP 159864107 · 2025Q4$65.9M0.05%-29.0%
Point72 Asset Management, L.P. FundCUSIP 159864107 · 2025Q4$44.2M0.07%n/a
TWO SIGMA INVESTMENTS, LP FundCUSIP 159864107 · 2025Q4$5.6M0.01%-58.5%
Bridgewater Associates, LP FundCUSIP 159864107 · 2025Q4$4.4M0.02%+10.8%
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 159864107 · 2025Q4$2M0.00%n/a
SOROS FUND MANAGEMENT LLC FundCUSIP 159864107 · 2025Q4$1.4M0.02%n/a

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.